Cargando...
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
BACKGROUND: Cerebral palsy (CP) is the most common cause of physical disabilities in children in high‐income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT‐A) is considered the first‐line treatment for focal spasticity in people with CP. OBJECTIVES: To...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779591/ https://ncbi.nlm.nih.gov/pubmed/31591703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001408.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|